USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$41.72B
Market Cap
20.82
P/E Ratio
0.45
EPS
$11.35
52 Week High
$8.69
52 Week Low
HEALTHCARE
Sector
| Field | Value (GBP) |
|---|---|
| Gross Profit | $6.9B |
| Total Revenue | $11B |
| Cost Of Revenue | $4.3B |
| Costof Goods And Services Sold | $4.3B |
| Operating Income | $2.2B |
| Selling General And Administrative | $4.5B |
| Research And Development | $298M |
| Operating Expenses | $4.7B |
| Investment Income Net | - |
| Net Interest Income | -$339M |
| Interest Income | $65M |
| Interest Expense | $394M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $196M |
| Income Before Tax | $1.9B |
| Income Tax Expense | $435M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1.5B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $2.3B |
| Ebitda | $2.5B |
| Net Income | $1.4B |
| Field | Value (GBP) |
|---|---|
| Total Assets | $34B |
| Total Current Assets | $5.7B |
| Cash And Cash Equivalents At Carrying Value | $2.2B |
| Cash And Short Term Investments | $2.2B |
| Inventory | $1.2B |
| Current Net Receivables | $1.9B |
| Total Non Current Assets | $29B |
| Property Plant Equipment | $1.9B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $18B |
| Intangible Assets Excluding Goodwill | $18B |
| Goodwill | $8.2B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $55M |
| Other Current Assets | $374M |
| Other Non Current Assets | - |
| Total Liabilities | $18B |
| Total Current Liabilities | $5.8B |
| Current Accounts Payable | $2B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.5B |
| Total Non Current Liabilities | $12B |
| Capital Lease Obligations | $123M |
| Long Term Debt | $8.5B |
| Current Long Term Debt | $1.4B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $10B |
| Other Current Liabilities | $2.1B |
| Other Non Current Liabilities | $28M |
| Total Shareholder Equity | $16B |
| Treasury Stock | - |
| Retained Earnings | $27B |
| Common Stock | $91M |
| Common Stock Shares Outstanding | $4.6B |
| Field | Value (GBP) |
|---|---|
| Operating Cashflow | $2.3B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $324M |
| Capital Expenditures | $250M |
| Change In Receivables | - |
| Change In Inventory | $216M |
| Profit Loss | - |
| Cashflow From Investment | $528M |
| Cashflow From Financing | -$1.5B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $570M |
| Dividend Payout Common Stock | $570M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$121M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $1.4B |
| Field | Value (GBP) |
|---|---|
| Gross Profit | $6.9B |
| Total Revenue | $11B |
| Cost Of Revenue | $4.3B |
| Costof Goods And Services Sold | $4.3B |
| Operating Income | $2.2B |
| Selling General And Administrative | $4.5B |
| Research And Development | $298M |
| Operating Expenses | $4.7B |
| Investment Income Net | - |
| Net Interest Income | -$339M |
| Interest Income | $65M |
| Interest Expense | $394M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $196M |
| Income Before Tax | $1.9B |
| Income Tax Expense | $435M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1.5B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $2.3B |
| Ebitda | $2.5B |
| Net Income | $1.4B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-08-15 |
| Declaration Date | 2025-08-04 |
| Record Date | 2025-08-15 |
| Payment Date | 2025-09-18 |
| Amount | 0.058542 |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
None